References
- Bjornsson TD, Callaghan JT, Einolf HJ, et al. (2003). The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815–32.
- Brocks DR. (2006). Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharm Drug Dispos 27:387–406.
- Chen F, Qi W, Sun J, et al. (2014). Urinary metabolites of isorhynchophylline in rats and their neuroprotective activities in the HT22 cell assay. Fitoterapia 97:156–63.
- Fu AK, Hung KW, Huang H, et al. (2014). Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease. Proc Natl Acad Sci USA 111:9959–64.
- Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70.
- Khojasteh SC, Prabhu S, Kenny JR, et al. (2011). Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 36:1–16.
- Lu JH, Tan JQ, Durairajan SS, et al. (2012). Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy. Autophagy 8:98–108.
- Ng YP, Or TC, Ip NY. (2015). Plant alkaloids as drug leads for Alzheimer's disease. Neurochem Int 89:260–70.
- Peng Y, Wu H, Zhang X, et al. (2015). A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica 45:961–77.
- Song R, Xu F, Zhang Z, et al. (2008). Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 22:1230–6.
- Tang X, Di X, Zhong Z, et al. (2016). In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes. J Pharm Biomed Anal 128:98–105.
- Wang J, Qi P, Hou J, et al. (2016). Profiling and identification of metabolites of isorhynchophylline in rats by ultra high performance liquid chromatography and linear ion trap Orbitrap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1033-1034:147–56.
- Wang W, Li X, Chen Y, et al. (2014). Structural elucidation of rat biliary metabolites of corynoxeine and their quantification using LC-MS(n). Biomed Chromatogr 28:1219–28.
- Wang W, Ma CM, Hattori M. (2010a). Metabolism and pharmacokinetics of rhynchophylline in rats. Biol Pharm Bull 33:669–76.
- Wang W, Ma CM, Hattori M. (2010b). Metabolism of isorhynchophylline in rats detected by LC-MS. J Pharm Pharm Sci 13:27–37.
- Wang X, Zheng M, Liu J, et al. (2017). Stereoselective pharmacokinetic study of rhynchophylline and isorhynchophylline epimers in rat plasma by liquid chromatography-tandem mass spectrometry. Xenobiotica 47:479–87.
- Xian YF, Lin ZX, Mao QQ, et al. (2012). Protective effect of isorhynchophylline against β-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol 32:353–60.
- Xian YF, Mao QQ, Wu JC, et al. (2014). Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. J Alzheimers Dis 39:331–46.
- Xie S, Shi Y, Wang Y, et al. (2013). Systematic identification and quantification of tetracyclic monoterpenoid oxindole alkaloids in Uncaria rhynchophylla and their fragmentations in Q-TOF-MS spectra. J Pharm Biomed Anal 81-82:56–64.
- Yang W, Zhang Y, Pan H, et al. (2017). Supercritical fluid chromatography for separation and preparation of tautomeric 7-epimeric spiro oxindole alkaloids from Uncaria macrophylla. J Pharm Biomed Anal 134:352–60.
- Zhang Q, Zhao JJ, Xu J, et al. (2015). Medicinal uses, phytochemistry and pharmacology of the genus Uncaria. J Ethnopharmacol 173:48–80.
- Zhao L, Qi W, Chen F, et al. (2016). Metabolic profile of isocorynoxeine in rats obtained by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Eur J Drug Metab Pharmacokinet 41:615–26.
- Zhou J, Zhou S. (2010). Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. J Ethnopharmacol 132:15–27.